Life Insurance with AFib: How Managed Cases Get Standard Rates (2026)

Why your TYPE of AFib drives the price

The cardiac workup underwriters want to see

The best-case line: the report that decides an AFib rate is your echocardiogram. “Lone” AFib — a normal echo with no underlying heart disease — can reach a top preferred class. The picture changes when the AFib comes with valve disease or a weakened heart muscle (cardiomyopathy). The same diagnosis can be priced very differently depending on what the echo shows, which is why the right carrier match matters.

The echo

An echocardiogram showing normal chambers, valves, and ejection fraction reframes everything. If yours is older than 2–3 years, a fresh one before applying often pays for itself in premium.

Stroke prevention

Here’s a surprise: being on a blood thinner like Eliquis or Xarelto usually helps your file, not hurts it. It tells the underwriter that AFib’s #1 danger — stroke — is being actively managed. It’s untreated risk that gets the decline stamp, not the medication.

Older charts run on warfarin, with regular blood draws to keep levels in range. Most people today are on a DOAC instead — Eliquis, Xarelto, Pradaxa, Savaysa — no routine monitoring, fewer food and drug hassles.

The one thing that raises eyebrows: a stroke-risk score high enough to call for a thinner, but no thinner in the chart and no explanation. That reads as an open question, and open questions get priced up. If your score is genuinely low and that is why you are not on one, fine — just get your cardiologist to say so in the chart. One sentence from them does more for your file than anything I can argue on your behalf.

What your CHA₂DS₂-VASc score means

Episode control

How often, how long, and when was the last one? Documented rhythm control or successful rate control with no recent ER visits reads beautifully.

The company AFib keeps

Thyroid problems, sleep apnea, drinking, and high blood pressure all feed AFib — and current guidelines treat managing those triggers as seriously as the rhythm drugs themselves. Treated triggers strengthen your story. My sleep apnea and blood pressure guides cover two of the big ones.

It cuts both ways on your application. AFib sitting next to untreated sleep apnea reads like an unfinished problem. The same AFib next to a CPAP compliance report reads like someone who is on top of it. These are also things you can still fix before you apply — weight included.

What you’ll pay: 2026 rate ranges

Monthly ranges for a $500,000, 20-year term, male non-smoker. Women run 15–25% less.

Estimates only — not a quote. Your actual offer is set at underwriting and varies by carrier, your full file, and your health at the time you apply.

Ablation, cardioversion & the reset button

Had a successful ablation? This is about as close to a reset button as AFib underwriting gets. Six to twelve months out with no recurrence, carriers start treating you like a dramatically better risk — some get close to normal-heart pricing after a clean year or two. Keep every follow-up EKG; they’re your receipts.

Mind the blanking period. The first three months after an ablation are called the blanking period, and episodes during that window are normal — they don’t mean the procedure failed, the heart is just settling. Your cardiologist knows that; an underwriter skimming a raw chart might not. So don’t apply the week after your procedure. Wait until the file shows the result, not the recovery — past the blanking period, off antiarrhythmic drugs, no recurrence documented. That is a very different story than “had an ablation.”

Cardioversions read as treatment events, not failures — but a few recent ones in a row suggest an unstable rhythm, so plan on 6–12 stable months before applying.

Had “a touch of AFib” years ago and nothing since? Get it documented. A single resolved episode with years of normal rhythm can underwrite almost as clean as no AFib at all — but only if your records actually say so.

What this looks like in practice

Illustrative examples — composite scenarios based on typical AFib underwriting, not actual clients.

The clean file — 58, paroxysmal. A few episodes a year, a structurally normal echo from last spring, on Eliquis because his score called for it, blood pressure controlled. Nothing dramatic in the chart — and that is the point. Nothing dramatic is what Standard looks like. His AFib was never really the question. His heart was, and the echo answered it.

The trigger nobody treated — 62, persistent. Persistent AFib, rate-controlled, no complaints — and undiagnosed sleep apnea sitting right next to it. The first read priced the pair, not the AFib. After a sleep study, three months of CPAP compliance data, and a current echo, the same heart was a materially better file. Same diagnosis. Different story.

Applied one month too early — 54, post-ablation. Ablation in January, application in February, still inside the blanking period. The chart showed exactly what a blanking period shows: episodes. He was not declined — he was told to come back. At nine months, off antiarrhythmics with no recurrence documented, the file read like a reset instead of a recovery. Same procedure, eight months of patience.

What to do next

1. Gather the cardiac paper trail: last echo, current meds, episode history, any ablation/cardioversion dates.

2. Run a quote or call me first — AFib is a condition I always shop informally before any formal application, because carrier appetite varies sharply.

3. If your workup is stale, see your cardiologist before applying. Fresh clean data beats old ambiguous data by a full rate class.